(1S,2S)-2-METHOXYCARBONYLCYCLOBUTANECARBOXYLIC ACID, 95%, 5g

Isobutyric acid, >=99%, for synthesis, 10 l, PE/steel

5-(4-Bromophenyl)isothiazole, 95%, 100mg

(1R,4S,4aR,9aS)-rel-4a-Methyl-1,4,4a,9a-tetrahydro-1,4-methanoanthracene-9,10-dione, 95.0%, 1g

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(((allyloxy)carbonyl)amino)propanoic acid, 98.0%, 1g

(1R,2R,4S,5S,7s)-9-Methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-ol, 95.0%, 1g

2H,2H,3H,3H-Perfluorooctanoic acid, 98%, 250mg

4-Chloro-2-iodoanisole>98.0%(GC)5g

2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-4-(trifluoromethoxy)phenol, 95.0%, 10g

5-[3-(trifluoromethyl)phenyl]-1H-pyrazole-4-carboxylic acid, 95.0%, 1g

5''-(4'-Formyl-[1,1'-biphenyl]-4-yl)-[1,1':4',1'':3'',1''':4''',1''''-quinquephenyl]-4,4''''-dicarbaldehyde, 97%, 1g

Tacrolimus Monohydrate>80.0%(HPLC)50mg

1,4-Diethoxybenzene, 95.0%, 25g